Overview Open-Label Study of Safety of H1337 in Healthy Volunteers Status: COMPLETED Trial end date: 2024-10-14 Target enrollment: Participant gender: Summary The trial will evaluate the safety of one dose regimen of H-1337 \[1% twice daily (b.i.d.)\] in both eyes in healthy volunteers.Phase: PHASE1 Details Lead Sponsor: D. Western Therapeutics Institute, Inc.